Transaction details
On March 17, 2026, director John T. Stout Jr. sold 2,500 shares of The Andersons, Inc. common stock at a price of $70.30 per share, producing total proceeds of $175,750. The sale was reported in a Form 4 filing with the Securities and Exchange Commission. The filing was signed on Stout's behalf by Melissa Trippel under a Limited Power of Attorney.
Shareholdings after the sale
Following the disposition, Stout directly holds 23,440.5719 shares of Andersons common stock. In addition, he indirectly owns 4,219 shares that are held in trust, as noted in the disclosure.
Market context
The director's sale took place while Andersons shares were trading near a 52-week high of $71.54. Over the previous 12 months the stock has gained approximately 62%.
Valuation note
InvestingPro analysis characterizes the roughly $2.3 billion company as appearing overvalued. That assessment is presented in the same context as the disclosed sale and may provide background for the decision to trim a direct stake. InvestingPro also offers Fair Value estimates and ProTips for ANDE as part of broader coverage across more than 1,400 U.S. equities.
Recent operational results
The Andersons posted fourth-quarter 2025 adjusted earnings of $2.04 per share, ahead of the analyst projection of $1.56 per share. Revenue for the quarter was $2.54 billion, below the consensus estimate of $3.28 billion. Management cited record production levels in the company's Renewables segment, which reported $54 million in pretax income driven by record ethanol production. The Agribusiness segment produced $46 million in pretax income amid a record corn harvest season.
Analyst stance
Benchmark reiterated its Buy rating on The Andersons and maintained a $75.00 price target, noting operational strengths and favorable tax credits as supporting factors. The firm pointed to the company's performance across its core segments when defending its view.
Key points
- Director John T. Stout Jr. sold 2,500 shares on March 17, 2026, for $70.30 per share, totaling $175,750.
- The transaction was disclosed in an SEC Form 4, executed by Melissa Trippel under a Limited Power of Attorney.
- The Andersons reported Q4 2025 adjusted EPS of $2.04 versus a $1.56 consensus, while revenue of $2.54 billion missed the $3.28 billion estimate. Benchmark continues to rate the stock Buy with a $75 target.
Risks and uncertainties
- Valuation concerns - InvestingPro classifies the roughly $2.3 billion company as appearing overvalued, which may influence investor sentiment in the market and the equities sector.
- Top-line softness - The company reported revenue below consensus expectations in Q4 2025, introducing uncertainty for revenue-dependent assessments within agribusiness and renewables market segments.
Closing note
The director sale, the firm's mixed quarterly results and outside valuation commentary together form the documented developments investors may consider when assessing Andersons' near-term outlook. The SEC filing and the company's reported quarterly figures provide the primary factual record for those assessments.